Legal & General Group
LMAT icon

Legal & General Group’s LeMaitre Vascular LMAT Stock Holding History

Legal & General Group’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.16M Sell
47,237
-4,865
-9% -$464K ﹤0.01% 1492
2025
Q4 		$4.23M Sell
52,102
-1,455
-3% -$125K ﹤0.01% 1652
2025
Q3 		$4.69M Sell
53,557
-1,464
-3% -$131K ﹤0.01% 1619
2025
Q2 		$4.57M Sell
55,021
-510
-0.9% -$42.6K ﹤0.01% 1593
2025
Q1 		$4.66M Sell
55,531
-2,222
-4% -$207K ﹤0.01% 1563
2024
Q4 		$5.32M Buy
57,753
+2,865
+5% +$276K ﹤0.01% 1546
2024
Q3 		$5.1M Sell
54,888
-119
-0.2% -$10.3K ﹤0.01% 1566
2024
Q2 		$4.53M Sell
55,007
-332
-0.6% -$24.4K ﹤0.01% 1573
2024
Q1 		$3.67M Buy
55,339
+119
+0.2% +$7.34K ﹤0.01% 1661
2023
Q4 		$3.13M Buy
55,220
+313
+0.6% +$16.4K ﹤0.01% 1734
2023
Q3 		$2.99M Sell
54,907
-546
-1% -$32.4K ﹤0.01% 1711
2023
Q2 		$3.73M Buy
55,453
+8,796
+19% +$537K ﹤0.01% 1615
2023
Q1 		$2.4M Sell
46,657
-692
-1% -$33.6K ﹤0.01% 1800
2022
Q4 		$2.18M Buy
47,349
+1,154
+2% +$54K ﹤0.01% 1841
2022
Q3 		$2.34M Buy
46,195
+426
+0.9% +$21.3K ﹤0.01% 1784
2022
Q2 		$2.08M Buy
45,769
+200
+0.4% +$8.95K ﹤0.01% 1865
2022
Q1 		$2.12M Sell
45,569
-506
-1% -$22.6K ﹤0.01% 1960
2021
Q4 		$2.31M Buy
46,075
+2,274
+5% +$118K ﹤0.01% 1971
2021
Q3 		$2.33M Buy
43,801
+7,647
+21% +$431K ﹤0.01% 1953
2021
Q2 		$2.21M Sell
36,154
-10,750
-23% -$571K ﹤0.01% 1924
2021
Q1 		$2.29M Buy
46,904
+1,054
+2% +$49.4K ﹤0.01% 1924
2020
Q4 		$1.86M Buy
45,850
+156
+0.3% +$5.58K ﹤0.01% 1923
2020
Q3 		$1.49M Buy
45,694
+812
+2% +$24.4K ﹤0.01% 1892
2020
Q2 		$1.18M Buy
44,882
+3,558
+9% +$93K ﹤0.01% 1925
2020
Q1 		$1.03M Buy
41,324
+30
+0.1% +$926 ﹤0.01% 1841
2019
Q4 		$1.49M Buy
41,294
+3,474
+9% +$120K ﹤0.01% 1923
2019
Q3 		$1.29M Buy
37,820
+663
+2% +$21.2K ﹤0.01% 1891
2019
Q2 		$1.04M Sell
37,157
-477
-1% -$13.3K ﹤0.01% 1945
2019
Q1 		$1.17M Buy
37,634
+4,093
+12% +$109K ﹤0.01% 1917
2018
Q4 		$792K Sell
33,541
-244
-0.7% -$6.66K ﹤0.01% 1979
2018
Q3 		$1.29M Buy
33,785
+3,360
+11% +$121K ﹤0.01% 1875
2018
Q2 		$1.02M Buy
30,425
+2,018
+7% +$71.8K ﹤0.01% 1918
2018
Q1 		$1.03M Buy
28,407
+879
+3% +$30.4K ﹤0.01% 1877
2017
Q4 		$877K Buy
27,528
+109
+0.4% +$3.73K ﹤0.01% 1931
2017
Q3 		$1.03M Buy
27,419
+4,323
+19% +$147K ﹤0.01% 1858
2017
Q2 		$721K Buy
23,096
+19,512
+544% +$563K ﹤0.01% 1945
2017
Q1 		$87K Hold
3,584
– – ﹤0.01% 2618
2016
Q4 		$91K Buy
3,584
+1,195
+50% +$26.5K ﹤0.01% 2623
2016
Q3 		$47K Hold
2,389
– – ﹤0.01% 2547
2016
Q2 		$33K Buy
+2,389
New +$36.5K ﹤0.01% 2679

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Legal & General Group's LMAT Position: Q1 2026 in Review

Legal & General Group reduced its LeMaitre Vascular (LMAT) stake by 9.3% in Q1 2026, selling an estimated $464K and leaving 47,237 shares worth $5.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1492.

Legal & General Group first reported a position in LMAT in Q2 2016 and has held it in 40 quarters since. The position peaked at $5.32M in Q4 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Legal & General Group held 47,237 shares of LeMaitre Vascular worth $5.16M as of Q1 2026.
  • Legal & General Group sold 4,865 LeMaitre Vascular shares in Q1 2026, an estimated $464K.
  • LeMaitre Vascular made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #1492 holding.
  • Legal & General Group first reported a position in LeMaitre Vascular in Q2 2016 and has held it in 40 quarters since.
  • Legal & General Group's LeMaitre Vascular position peaked at $5.32M in Q4 2024.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.